Lauren E Abrey

Lauren E Abrey

UNVERIFIED PROFILE

Are you Lauren E Abrey?   Register this Author

Register author
Lauren E Abrey

Lauren E Abrey

Publications by authors named "Lauren E Abrey"

Are you Lauren E Abrey?   Register this Author

100Publications

2151Reads

13Profile Views

Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.

J Neurooncol 2019 Sep 19;144(2):403-407. Epub 2019 Jul 19.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03243-7DOI Listing
September 2019

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Neuro Oncol 2017 Oct;19(10):1380-1390

Memorial Sloan Kettering Cancer Center, New York, New York,USA; Northwestern Memorial Hospital, Chicago, Illinois, USA; NorthShore University, Evanston, Illinois,USA; University of Calgary, Calgary, Alberta, Canada; Massachusetts General Hospital, Boston, Massachusetts, USA; MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596171PMC
October 2017

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.

Neuro Oncol 2017 01 31;19(1):89-98. Epub 2016 Aug 31.

UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (B.M.E., R.J.H., D.C.W., K.L., O.Z.); Dept. of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (B.M.E., R.J.H., D.C.W., K.L., O.Z., W.B.P.); Dept. of Physics and Biology in Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (B.M.E.); Dept. of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada (W.P.M.);H. Lee Moffitt Cancer Center, Tampa, Florida (S.S.); F. Hoffman-La Roche, Ltd., Basel, Switzerland (L.E.A.); Exelixis, South San Francisco, California (D.T.A., G.M.S., C.H.); Dept. of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California (A.L., P.L.N., T.F.C.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (P.Y.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193027PMC
January 2017

Reply to T.J. Kruser et al.

J Clin Oncol 2016 Apr 16;34(11):1282-3. Epub 2016 Feb 16.

University of California, Los Angeles, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.2438DOI Listing
April 2016

Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial.

J Clin Oncol 2015 Sep 29;33(25):2735-44. Epub 2015 Jun 29.

Thomas Sandmann, Richard Bourgon, Congfen Li, Samir Kharbanda, Franklin Peale, Priti Hegde, Heidi S. Phillips, and Carlos Bais, Genentech, South San Francisco; Timothy Cloughesy and Albert Lai, University of California Los Angeles, Los Angeles, CA; Josep Garcia, Nicola Moore, and Lauren E. Abrey F. Hoffmann-La Roche, Basel, Switzerland; Olivier L. Chinot, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Centre Hospitalier Universitaire Timone, Marseille, France; Wolfgang Wick, University Medical Center, Heidelberg, Germany; Ryo Nishikawa, Saitama Medical University, Saitama, Japan; Warren Mason, Princess Margaret Hospital, Toronto, Ontario, Canada; Roger Henriksson, Regional Cancer Center Stockholm, Stockholm; and Umeå University, Umeå, Sweden; and Frank Saran, Royal Marsden National Health Service Foundation Trust, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.61.5005
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.61.5005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015426PMC
September 2015

Radiotherapy and temozolomide for anaplastic astrocytic gliomas.

J Neurooncol 2015 May 29;123(1):129-34. Epub 2015 Apr 29.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1771-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606458PMC
May 2015

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Neuro Oncol 2015 Jan 6;17(1):116-21. Epub 2014 Aug 6.

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York (T.J.K., S.K., A.B.L., C.P.N., L.M.D., I.G., L.E.A., A.O.); Center for Neuro-Oncology, Dana-Farber Cancer Institute/Brigham and Women's Center, Boston, Massachusetts (P.W., K.L., S.H., A.N., J.D., E.Q.L.); Department of Neurology, University of Virginia, Charlottesville, Virginia (D.S., B.P.); Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts (S.R.P., T.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483051PMC
January 2015

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors.

Neuro Oncol 2014 Nov 4;16(11):1541-6. Epub 2014 Jul 4.

Departments of Neurology (A.B.L., F.M.I., L.E.A., L.M.D.), Pathology (S.C.J., M.K.R.), Epidemiology & Biostatistics (A.S.R., K.S.P.), and the Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York; University of California, Los Angeles, Los Angeles, California (T.F.C.); Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (K.D.A., A.L.R.); Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (A.F.E., D.N.L.); NorthShore University Health System, Evanston Hospital Kellogg Cancer Center, University of Chicago, Pritzker School of Medicine, Evanston, Illinois (N.A.P.); London Regional Cancer Program, London, Ontario, Canada (B.J.F.); Barrow Neurological Institute, Phoenix, Arizona (L.S.A.); University of Calgary, Calgary, Alberta, Canada (J.G.C., G.B.R.U.); Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts (P.Y.W.); Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Children's Hospital Boston, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); University of Virginia Health System, Charlottesville, Virginia (D.S.); University of Wisconsin, Madison, Wisconsin (H.I.R., B.G.R.); University of Washington, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, Seattle, Washington (M.C.C.); Princess Margaret Hospital, Toronto, Ontario, Canada (W.P.M.); Albany Medical Center, Albany, New York (S.A.W.); Kaiser Permanente-Los Angeles Medical Center, Los Angeles, California (R.M.G.); Clemenceau Medical Center, Beirut, Lebanon and Université Saint-Esprit de Kaslik, Byblos, Lebanon (F.G.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201067PMC
November 2014

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

J Clin Oncol 2013 Nov 7;31(31):3971-9. Epub 2013 Oct 7.

Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Anne S. Reiner, Kathy Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, and Antonio Omuro, Memorial Sloan-Kettering Cancer Center; Rose K. Lai, Columbia University, New York, NY; Jeffrey J. Raizer and Sean Grimm, Northwestern University, Chicago, IL; David Schiff, University of Virginia, Charlottesville, VA; and Barbara Grant, University of Vermont, Burlington, VT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.50.4910DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569679PMC
November 2013

Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.

Curr Neurol Neurosci Rep 2013 May;13(5):347

Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, 264 Rue Saint Pierre, 13005, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-013-0347-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631110PMC
May 2013

Patterns of failure after concurrent bevacizumab and hypofractionated stereotactic radiation therapy for recurrent high-grade glioma.

Int J Radiat Oncol Biol Phys 2013 Mar 3;85(3):636-42. Epub 2012 Jul 3.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.05.031DOI Listing
March 2013

A phase II trial of oral gimatecan for recurrent glioblastoma.

J Neurooncol 2013 Feb 12;111(3):347-53. Epub 2012 Dec 12.

Johnnie L. Cochran Jr. Brain Tumor Center, 8631 West Third St, Suite 410E, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-1023-0DOI Listing
February 2013

Post-treatment T1 shortening in primary CNS lymphoma.

J Neurooncol 2013 Jan 17;111(1):25-31. Epub 2012 Oct 17.

Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0984-3DOI Listing
January 2013

The impact of chemotherapy on cognitive outcomes in adults with primary brain tumors.

Authors:
Lauren E Abrey

J Neurooncol 2012 Jun 17;108(2):285-90. Epub 2012 Feb 17.

Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0807-6DOI Listing
June 2012

Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Neuro Oncol 2012 Jan 19;14(1):101-8. Epub 2011 Oct 19.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245999PMC
January 2012

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

Leuk Lymphoma 2011 Oct 24;52(10):1891-7. Epub 2011 Jun 24.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.585527DOI Listing
October 2011

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

Neuro Oncol 2011 Jun 9;13(6):660-8. Epub 2011 May 9.

Section of Neuropsychology, Department of Neuro-Oncology, Unit 431, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107095PMC
June 2011

Late relapse in primary central nervous system lymphoma: clonal persistence.

Neuro Oncol 2011 May 3;13(5):525-9. Epub 2011 Mar 3.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nor014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093334PMC
May 2011

Magnetic resonance spectroscopy imaging in radiotherapy planning for recurrent glioma.

Med Phys 2011 May;38(5):2724-30

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.3574884DOI Listing
May 2011

Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.

Radiat Oncol 2011 Jan 7;6. Epub 2011 Jan 7.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://ro-journal.biomedcentral.com/articles/10.1186/1748-71
Publisher Site
http://dx.doi.org/10.1186/1748-717X-6-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025871PMC
January 2011

Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

Cancer 2010 Oct;116(19):4605-12

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25363DOI Listing
October 2010

Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas.

Target Oncol 2010 Sep 16;5(3):193-200. Epub 2010 Sep 16.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0160-7DOI Listing
September 2010

Hematology. Individualized methotrexate dosing in primary CNS lymphoma.

Authors:
Lauren E Abrey

Nat Rev Clin Oncol 2010 Jun;7(6):306-7

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2010.66
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2010.66DOI Listing
June 2010

Clinical monograph: Clinical considerations for older patients with glioblastoma.

Clin Adv Hematol Oncol 2010 Jan;8(1 Suppl 1):1-14; quiz 15-6

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
January 2010

Neurological outcome of long-term glioblastoma survivors.

J Neurooncol 2009 Dec 26;95(3):301-305. Epub 2009 Jun 26.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-9946-9DOI Listing
December 2009

Prognosis and patterns of care in elderly patients with glioma.

Cancer 2009 Dec;115(23):5534-40

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24612DOI Listing
December 2009

Primary central nervous system lymphoma.

Authors:
Lauren E Abrey

Curr Opin Neurol 2009 Dec;22(6):675-80

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0b013e328332533bDOI Listing
December 2009

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.

Int J Radiat Oncol Biol Phys 2009 Sep 23;75(1):156-63. Epub 2009 Jan 23.

Department of Neurosurgery, The Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.10.043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659401PMC
September 2009

Maintenance therapy for central nervous system lymphoma with rituximab.

Leuk Lymphoma 2009 Sep;50(9):1548-51

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190903128645DOI Listing
September 2009

Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007).

Cancer 2009 Aug;115(16):3758-66

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24413
Publisher Site
http://dx.doi.org/10.1002/cncr.24413DOI Listing
August 2009

Current management of metastatic brain disease.

Neurotherapeutics 2009 Jul;6(3):598-603

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nurt.2009.04.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084194PMC
July 2009

Therapeutic challenges in primary CNS lymphoma.

Lancet Neurol 2009 Jun;8(6):581-92

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(09)70091-2DOI Listing
June 2009

Intracranial dural metastases.

Cancer 2009 May;115(9):1947-53

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24203DOI Listing
May 2009

Gross total resection of low-grade glioma in adults.

Authors:
Lauren E Abrey

Curr Neurol Neurosci Rep 2009 May;9(3):181-2

Departmentof Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
May 2009

A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM).

J Neurooncol 2009 Mar 19;92(1):99-105. Epub 2008 Nov 19.

Neuro-Oncology Branch, National Cancer Institute, 9030 Old Georgetown Road, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9741-zDOI Listing
March 2009

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.

J Neurooncol 2009 Feb 1;91(3):315-21. Epub 2008 Nov 1.

Department of Neurology, Memorial-Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9716-0DOI Listing
February 2009

Patterns of care in elderly glioblastoma patients.

Ann Neurol 2008 Dec;64(6):628-34

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.21521DOI Listing
December 2008

Utility of brain FDG-PET in primary CNS lymphoma.

Clin Adv Hematol Oncol 2008 Nov;6(11):818-20, 840

Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
November 2008

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.

Leuk Lymphoma 2008 Sep;49(9):1710-6

Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802238560DOI Listing
September 2008

Bevacizumab in recurrent malignant glioma.

Authors:
Lauren E Abrey

Curr Neurol Neurosci Rep 2008 May;8(3):233-4

View Article

Download full-text PDF

Source
May 2008

The utility of body FDG PET in staging primary central nervous system lymphoma.

Neuro Oncol 2008 Apr 20;10(2):223-8. Epub 2008 Feb 20.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1215/15228517-2007-061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613825PMC
April 2008

A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.

J Neurooncol 2008 Mar 7;87(1):85-90. Epub 2007 Nov 7.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-007-9491-3
Publisher Site
http://dx.doi.org/10.1007/s11060-007-9491-3DOI Listing
March 2008

Imaging of lymphoma of the central nervous system, spine, and orbit.

Radiol Clin North Am 2008 Mar;46(2):339-61, ix

Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York Presbyterian Hospital/Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rcl.2008.04.003DOI Listing
March 2008

Longitudinal cognitive follow-up in low grade gliomas.

J Neurooncol 2008 Feb 10;86(3):321-7. Epub 2007 Oct 10.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9474-4DOI Listing
February 2008

Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.

Cancer 2008 Jan;112(1):151-6

Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23149DOI Listing
January 2008

Chemotherapy for brain metastases: breast, gynecologic and non-melanoma skin malignancies.

Cancer Treat Res 2007 ;136:185-97

Memorial Sloan-Kettering Cancer Center, Department of Neurology, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-69222-7_10DOI Listing
January 2008

Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma.

Cancer 2007 Dec;110(11):2528-34

Department of Neurology, Memorial Sloan- Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23077DOI Listing
December 2007

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.

J Neurooncol 2007 Nov 27;85(2):217-22. Epub 2007 Jun 27.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9408-1DOI Listing
November 2007

Capecitabine therapy of central nervous system metastases from breast cancer.

J Neurooncol 2007 Nov 5;85(2):223-7. Epub 2007 Jul 5.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-007-9409-0DOI Listing
November 2007

Primary central nervous system lymphoma.

Neurol Clin 2007 Nov;25(4):1193-207, xi

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ncl.2007.07.001DOI Listing
November 2007

Patterns of treatment in older adults with primary central nervous system lymphoma.

Cancer 2007 Sep;110(6):1338-44

Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22907DOI Listing
September 2007

Diagnosis and management of primary intraocular lymphoma: an update.

Clin Ophthalmol 2007 Sep;1(3):247-58

Department of Hematology, Oncology and Transfusion Medicine, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701132PMC
September 2007

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma.

Neurology 2007 Sep;69(11):1178-82

Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000276986.19602.c1DOI Listing
September 2007

Primary central nervous system lymphoma.

Semin Radiat Oncol 2007 Jul;17(3):223-9

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2007.02.008DOI Listing
July 2007

Anaplastic oligodendroglioma.

Authors:
Lauren E Abrey

Curr Neurol Neurosci Rep 2007 May;7(3):189-90

View Article

Download full-text PDF

Source
May 2007

Intracranial hemorrhage in patients treated with bevacizumab and low-molecular weight heparin.

Clin Adv Hematol Oncol 2007 May;5(5):375-6; discussion 377-9

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
May 2007

Brain metastases: old problem, new strategies.

Hematol Oncol Clin North Am 2007 Apr;21(2):369-88

Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2007.03.009DOI Listing
April 2007

Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy?

Nat Clin Pract Oncol 2007 Feb 16;4(2):78-9. Epub 2007 Jan 16.

Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0690DOI Listing
February 2007

Retinopathy in survivors of primary central nervous system lymphoma.

Neurology 2006 Dec;67(11):2060-2

Memorial Sloan-Kettering Cancer Center, Department of Neurology, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.neurology.org/cgi/doi/10.1212/01.wnl.0000247679.8
Publisher Site
http://dx.doi.org/10.1212/01.wnl.0000247679.87738.1eDOI Listing
December 2006

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community.

Leuk Lymphoma 2006 Dec;47(12):2449-52

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600881272DOI Listing
December 2006

Primary dural lymphomas: a review.

Neurosurg Focus 2006 Nov 15;21(5):E5. Epub 2006 Nov 15.

Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, USA.

View Article

Download full-text PDF

Source
November 2006